Literature DB >> 22016832

Base excision repair targets for cancer therapy.

Grigory L Dianov1.   

Abstract

Cellular DNA repair is a frontline system that is responsible for maintaining genome integrity and thus preventing premature aging and cancer by repairing DNA lesions and strand breaks caused by endogenous and exogenous mutagens. However, it is also the principal cellular system in cancer cells that counteracts the killing effect of the major cancer treatments e.g. chemotherapy and ionizing radiation. The major goal of this review is to critically exam the base excision repair pathway and mechanisms regulating base excision repair capacity as a potential targets for improving cancer therapy.

Entities:  

Keywords:  DNA repair; base excision; cancer therapy; chemotherapy; ionizing radiation

Year:  2011        PMID: 22016832      PMCID: PMC3196283     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  58 in total

1.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

2.  Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.

Authors:  M R Kelley; L Cheng; R Foster; R Tritt; J Jiang; J Broshears; M Koch
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

3.  Two pathways for base excision repair in mammalian cells.

Authors:  G Frosina; P Fortini; O Rossi; F Carrozzino; G Raspaglio; L S Cox; D P Lane; A Abbondandolo; E Dogliotti
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

4.  Requirement of mammalian DNA polymerase-beta in base-excision repair.

Authors:  R W Sobol; J K Horton; R Kühn; H Gu; R K Singhal; R Prasad; K Rajewsky; S H Wilson
Journal:  Nature       Date:  1996-01-11       Impact factor: 49.962

5.  DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.

Authors:  Casey Lee; Brian A Smith; Keya Bandyopadhyay; Ruth A Gjerset
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

6.  Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.

Authors:  D H Moore; H Michael; R Tritt; S H Parsons; M R Kelley
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

7.  DNA polymerase beta promotes recruitment of DNA ligase III alpha-XRCC1 to sites of base excision repair.

Authors:  Jason L Parsons; Irina I Dianova; Sarah L Allinson; Grigory L Dianov
Journal:  Biochemistry       Date:  2005-08-09       Impact factor: 3.162

8.  Role of poly(ADP-ribose) formation in DNA repair.

Authors:  M S Satoh; T Lindahl
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

9.  A DNA polymerase beta mutant from colon cancer cells induces mutations.

Authors:  Tieming Lang; Mausumi Maitra; Daniela Starcevic; Shu-Xia Li; Joann B Sweasy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-09       Impact factor: 11.205

10.  Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair.

Authors:  Y Matsumoto; K Kim
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  8 in total

Review 1.  Unboxing the molecular modalities of mutagens in cancer.

Authors:  Smita Kumari; Sudhanshu Sharma; Dia Advani; Akanksha Khosla; Pravir Kumar; Rashmi K Ambasta
Journal:  Environ Sci Pollut Res Int       Date:  2021-10-05       Impact factor: 5.190

2.  Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma.

Authors:  Marianna Avitabile; Vito Alessandro Lasorsa; Sueva Cantalupo; Antonella Cardinale; Flora Cimmino; Annalaura Montella; Dalila Capasso; Riccardo Haupt; Loredana Amoroso; Alberto Garaventa; Alessandro Quattrone; Maria Valeria Corrias; Achille Iolascon; Mario Capasso
Journal:  J Cell Mol Med       Date:  2020-02-27       Impact factor: 5.310

Review 3.  Evolving insights: how DNA repair pathways impact cancer evolution.

Authors:  Jiadong Zhou; Xiao Albert Zhou; Ning Zhang; Jiadong Wang
Journal:  Cancer Biol Med       Date:  2020-12-15       Impact factor: 4.248

4.  PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations.

Authors:  Alexander von Werdt; Laura Brandt; Orlando D Schärer; Mark A Rubin
Journal:  JCO Precis Oncol       Date:  2021-10-22

5.  Role of p97/VCP (Cdc48) in genome stability.

Authors:  Bruno Vaz; Swagata Halder; Kristijan Ramadan
Journal:  Front Genet       Date:  2013-04-30       Impact factor: 4.599

Review 6.  Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.

Authors:  Sabine Hombach-Klonisch; Suchitra Natarajan; Thatchawan Thanasupawat; Manoj Medapati; Alok Pathak; Saeid Ghavami; Thomas Klonisch
Journal:  Front Endocrinol (Lausanne)       Date:  2014-03-25       Impact factor: 5.555

7.  IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells.

Authors:  Saman Maleki Vareki; Di Chen; Christine Di Cresce; Peter J Ferguson; Rene Figueredo; Macarena Pampillo; Mateusz Rytelewski; Mark Vincent; Weiping Min; Xiufen Zheng; James Koropatnick
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

8.  Versatile cell-based assay for measuring DNA alkylation damage and its repair.

Authors:  Yong Li; Peng Mao; Evelina Y Basenko; Zachary Lewis; Michael J Smerdon; Wioletta Czaja
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.